{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:12:44Z","timestamp":1769184764631,"version":"3.49.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.vaccine.2009.10.114","type":"journal-article","created":{"date-parts":[[2009,11,6]],"date-time":"2009-11-06T04:12:36Z","timestamp":1257480756000},"page":"1084-1093","source":"Crossref","is-referenced-by-count":55,"title":["Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime\u2013boost regimen"],"prefix":"10.1016","volume":"28","author":[{"given":"Yasir A.W.","family":"Skeiky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd M.","family":"Lasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Stagliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerabadran","family":"Dheenadhayalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret Ann","family":"Goetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Cantarero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall J.","family":"Basaraba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Kromann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Bruce","family":"McMclain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerald C.","family":"Sadoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2009.10.114_bib1","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.1093\/clinids\/11.Supplement_2.S353","article-title":"The BCG story: lessons from the past and implications for the future","volume":"11","author":"Fine","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2009.10.114_bib2","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis","volume":"22","author":"Rodrigues","year":"1993","journal-title":"Int J Epidemiol"},{"issue":"9","key":"10.1016\/j.vaccine.2009.10.114_bib3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"issue":"1 Pt 1","key":"10.1016\/j.vaccine.2009.10.114_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2009.10.114_bib5","first-page":"200","article-title":"Does the efficacy of BCG decline with time since vaccination?","volume":"2","author":"Sterne","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2009.10.114_bib6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrmicro1419","article-title":"Advances in tuberculosis vaccine strategies","volume":"4","author":"Skeiky","year":"2006","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.10.114_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1586\/14760584.1.3.341","article-title":"Tuberculosis vaccines: the past, present and future","volume":"1","author":"Wang","year":"2002","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2009.10.114_bib8","first-page":"23","article-title":"Prime\u2013boost immunization strategies for infectious diseases","volume":"4","author":"McShane","year":"2002","journal-title":"Curr Opin Mol Ther"},{"issue":"17","key":"10.1016\/j.vaccine.2009.10.114_bib9","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.2165\/00003495-200565170-00002","article-title":"Tuberculosis vaccines: current progress","volume":"65","author":"Orme","year":"2005","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.vaccine.2009.10.114_bib10","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.10.114_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1054\/tube.2000.0271","article-title":"Optimal models to evaluate the protective efficacy of tuberculosis vaccines","volume":"81","author":"Griffin","year":"2001","journal-title":"Tuberculosis (Edinb)"},{"issue":"11","key":"10.1016\/j.vaccine.2009.10.114_bib12","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1128\/IAI.71.11.6411-6419.2003","article-title":"Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination","volume":"71","author":"Buddle","year":"2003","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2009.10.114_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0378-1135(01)00461-8","article-title":"Vaccination of the brushtail possum (Trichosurus vulpecula) against Mycobacterium bovis infection with bacille Calmette-Guerin: the response to multiple doses","volume":"84","author":"Corner","year":"2002","journal-title":"Vet Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.10.114_bib14","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1128\/IAI.00517-06","article-title":"Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis","volume":"74","author":"Santosuosso","year":"2006","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2009.10.114_bib15","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/IAI.69.6.4174-4176.2001","article-title":"Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis","volume":"69","author":"Feng","year":"2001","journal-title":"Infect Immun"},{"issue":"9493","key":"10.1016\/j.vaccine.2009.10.114_bib16","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet"},{"issue":"4 Pt 1","key":"10.1016\/j.vaccine.2009.10.114_bib17","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/ajrccm.157.4.9706037","article-title":"Bacillus Calmette-Guerin revaccination questionable with low tuberculosis incidence","volume":"157","author":"Tala-Heikkila","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.vaccine.2009.10.114_bib18","first-page":"399","article-title":"Rates of adverse reactions to first and second doses of BCG vaccination: results of a large community trial in Brazilian schoolchildren","volume":"7","author":"Dourado","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2009.10.114_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2249.2004.02609.x","article-title":"In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis","volume":"138","author":"Al-Attiyah","year":"2004","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.10.114_bib20","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.4049\/jimmunol.165.11.6463","article-title":"Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans","volume":"165","author":"Geluk","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.10.114_bib21","series-title":"Tuberculosis and the tubercle bacillus","first-page":"71","article-title":"Immune-based methods","author":"Laal","year":"2005"},{"issue":"7","key":"10.1016\/j.vaccine.2009.10.114_bib22","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1128\/IAI.68.7.3933-3940.2000","article-title":"Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines","volume":"68","author":"Mustafa","year":"2000","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2009.10.114_bib23","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1128\/IAI.67.8.3998-4007.1999","article-title":"Cloning, expression, and immunological evaluation of two putative secreted serine protease antigens of Mycobacterium tuberculosis","volume":"67","author":"Skeiky","year":"1999","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2009.10.114_bib24","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1128\/IAI.70.10.5446-5453.2002","article-title":"Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family","volume":"70","author":"Skjot","year":"2002","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2009.10.114_bib25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/IAI.68.1.214-220.2000","article-title":"Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens","volume":"68","author":"Skjot","year":"2000","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2009.10.114_bib26","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1128\/IAI.68.12.7144-7148.2000","article-title":"Human CD8(+) T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and healthy BCG-vaccinated controls in The Gambia","volume":"68","author":"Smith","year":"2000","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2009.10.114_bib27","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1128\/IAI.72.10.6148-6150.2004","article-title":"Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model","volume":"72","author":"Olsen","year":"2004","journal-title":"Infect Immun"},{"issue":"21","key":"10.1016\/j.vaccine.2009.10.114_bib28","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1016\/j.vaccine.2004.11.051","article-title":"Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6","volume":"23","author":"Langermans","year":"2005","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2009.10.114_bib29","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1086\/425931","article-title":"Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosis","volume":"190","author":"Doherty","year":"2004","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2009.10.114_bib30","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1128\/IAI.69.5.2773-2778.2001","article-title":"Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6","volume":"69","author":"Weinrich Olsen","year":"2001","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2009.10.114_bib31","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1086\/314640","article-title":"Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis","volume":"179","author":"Ravn","year":"1999","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2009.10.114_bib32","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1164\/ajrccm.163.4.2009100","article-title":"Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells","volume":"163","author":"Lalvani","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.vaccine.2009.10.114_bib33","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1128\/JCM.42.6.2379-2387.2004","article-title":"Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection","volume":"42","author":"Brock","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.10.114_bib34","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.4049\/jimmunol.174.10.6332","article-title":"Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy","volume":"174","author":"Dietrich","year":"2005","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.10.114_bib35","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1128\/IAI.72.10.5963-5971.2004","article-title":"Magnetic resonance imaging of pulmonary lesions in guinea pigs infected with Mycobacterium tuberculosis","volume":"72","author":"Kraft","year":"2004","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2009.10.114_bib36","first-page":"422","article-title":"Host-parasite relationships in experimental airborne tuberculosis. 3. Relevance of microbial enumeration to acquired resistance in guinea pigs","volume":"102","author":"Wiegeshaus","year":"1970","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.vaccine.2009.10.114_bib37","series-title":"Evaluation of chemotherapeutic agents","first-page":"196","article-title":"The clinical evaluation of chemotherapeutic agents in cancer","author":"Karnofsky","year":"1949"},{"key":"10.1016\/j.vaccine.2009.10.114_bib38","series-title":"Handbook of tuberculosis","article-title":"Immunopathology of Tuberculosis","author":"Saunders BM","year":"2008"},{"issue":"9","key":"10.1016\/j.vaccine.2009.10.114_bib39","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1128\/IAI.00332-06","article-title":"Pulmonary lymphatics are primary sites of Mycobacterium tuberculosis infection in guinea pigs infected by aerosol","volume":"74","author":"Basaraba","year":"2006","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2009.10.114_bib40","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.tube.2007.12.003","article-title":"Disseminated disease severity as a measure of virulence of Mycobacterium tuberculosis in the guinea pig model","volume":"88","author":"Palanisamy","year":"2008","journal-title":"Tuberculosis (Edinb)"},{"issue":"9","key":"10.1016\/j.vaccine.2009.10.114_bib41","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1920","article-title":"Envisioning future strategies for vaccination against tuberculosis","volume":"6","author":"Kaufmann","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2009.10.114_bib42","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1517\/14712598.4.9.1493","article-title":"Tuberculosis vaccine development: research, regulatory and clinical strategies","volume":"4","author":"Brennan","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"10.1016\/j.vaccine.2009.10.114_bib43","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1128\/CMR.18.4.687-702.2005","article-title":"Vaccines for tuberculosis: novel concepts and recent progress","volume":"18","author":"Doherty","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.vaccine.2009.10.114_bib44","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1128\/IAI.69.4.2714-2717.2001","article-title":"Boosting vaccine for tuberculosis","volume":"69","author":"Brooks","year":"2001","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2009.10.114_bib45","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1128\/IAI.72.11.6471-6479.2004","article-title":"Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime\u2013Rv3407 DNA boost vaccination against tuberculosis","volume":"72","author":"Mollenkopf","year":"2004","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2009.10.114_bib46","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.vaccine.2004.07.036","article-title":"A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity","volume":"23","author":"Derrick","year":"2004","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2009.10.114_bib47","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1016\/j.vaccine.2005.12.066","article-title":"Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv","volume":"24","author":"Romano","year":"2006","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2009.10.114_bib48","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.4049\/jimmunol.177.9.6353","article-title":"Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity","volume":"177","author":"Dietrich","year":"2006","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.10.114_bib49","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1128\/IAI.00004-07","article-title":"Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon","volume":"75","author":"Radosevic","year":"2007","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2009.10.114_bib50","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1128\/IAI.73.8.4676-4683.2005","article-title":"Enhancing the protective efficacy of Mycobacterium bovis BCG vaccination against tuberculosis by boosting with the Mycobacterium tuberculosis major secretory protein","volume":"73","author":"Horwitz","year":"2005","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2009.10.114_bib51","doi-asserted-by":"crossref","first-page":"e3790","DOI":"10.1371\/journal.pone.0003790","article-title":"rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime\u2013boost setting with an adenovirus 35 tuberculosis vaccine vector","volume":"3","author":"Magalhaes","year":"2008","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.vaccine.2009.10.114_bib52","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1128\/IAI.72.11.6622-6632.2004","article-title":"The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs","volume":"72","author":"Brandt","year":"2004","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2009.10.114_bib53","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1128\/IAI.74.2.1416-1418.2006","article-title":"Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing Mycobacterial antigen 85A and Mycobacterium bovis BCG","volume":"74","author":"Vordermeier","year":"2006","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2009.10.114_bib54","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1128\/IAI.73.6.3814-3816.2005","article-title":"Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs","volume":"73","author":"Williams","year":"2005","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.10.114_bib55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tube.2004.09.009","article-title":"Evaluation of vaccines in the EU TB vaccine cluster using a guinea pig aerosol infection model of tuberculosis","volume":"85","author":"Williams","year":"2005","journal-title":"Tuberculosis (Edinb)"},{"issue":"33","key":"10.1016\/j.vaccine.2009.10.114_bib56","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1016\/j.vaccine.2009.05.048","article-title":"Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2009.10.114_bib57","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1128\/IAI.00434-08","article-title":"A Replication-Limited Recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG","volume":"76","author":"Tullius","year":"2008","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2009.10.114_bib58","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest"},{"issue":"34","key":"10.1016\/j.vaccine.2009.10.114_bib59","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1016\/j.vaccine.2009.05.050","article-title":"Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates","volume":"27","author":"Larsen","year":"2009","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2009.10.114_bib60","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.4049\/jimmunol.154.7.3359","article-title":"Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice","volume":"154","author":"Andersen","year":"1995","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.10.114_bib61","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm0896-893","article-title":"Immunogenicity and protective efficacy of a tuberculosis DNA vaccine","volume":"2","author":"Huygen","year":"1996","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.vaccine.2009.10.114_bib62","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/IAI.66.6.2951-2959.1998","article-title":"Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis","volume":"66","author":"Baldwin","year":"1998","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2009.10.114_bib63","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1128\/JCM.38.9.3285-3290.2000","article-title":"Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG","volume":"38","author":"Dillon","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2009.10.114_bib64","series-title":"Keystone symposium on molecular and cellular biology","first-page":"59","article-title":"Subunit vaccines against tuberculosis","author":"Andersen","year":"2007"},{"key":"10.1016\/j.vaccine.2009.10.114_bib65","series-title":"Keystone symposia on molecular and cellular biology","first-page":"50","article-title":"Characterization of IC31, a novel multipurpose adjuvant with a profile matching the need of TB vaccines","author":"Gabain","year":"2007"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2009.10.114_bib66","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1472-9792(02)00079-3","article-title":"Hematogenous reseeding of the lung in low-dose, aerosol-infected guinea pigs: unique features of the host-pathogen interface in secondary tubercles","volume":"83","author":"McMurray","year":"2003","journal-title":"Tuberculosis (Edinb)"},{"issue":"3","key":"10.1016\/j.vaccine.2009.10.114_bib67","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.vaccine.2005.07.103","article-title":"Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations","volume":"24","author":"Basaraba","year":"2006","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.10.114_bib68","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tube.2004.09.015","article-title":"Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials","volume":"85","author":"McShane","year":"2005","journal-title":"Tuberculosis (Edinb)"},{"issue":"11","key":"10.1016\/j.vaccine.2009.10.114_bib69","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0901665X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0901665X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T08:40:29Z","timestamp":1685176829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0901665X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0264410X0901665X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.10.114","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}